ClinicalTrials.Veeva

Menu

Dietary Salt in Rheumatoid Arthritis

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Completed

Conditions

Rheumatoid Arthritis

Treatments

Other: salt

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03649178
R01HL140145 (U.S. NIH Grant/Contract)
141610

Details and patient eligibility

About

In this study investigators propose to address the following hypotheses: 1) Reduction in dietary sodium will decrease inflammation in patients with rheumatoid arthritis (RA). 2) Reduction in dietary sodium will decrease blood pressure in patients with RA. 3) Reduction in dietary sodium will decrease tissue sodium in patients with RA.

Full description

The study is a random-order, 2 period crossover study with washout. Participants will be randomly assigned to be on the high-sodium diet (200mmol/24hours x 8weeks) or low-sodium diet (50mmol/24hours x 8 weeks ) with crossover separated by 4-week washout period. Investigators will allow a 7-day window on the diet (i.e., to facilitate scheduling the diet can be between 7-9 weeks), and investigators will allow a 1-week window for the washout (i.e., washout can be 3-5 weeks).

Investigators will measure changes in inflammation (as measured by DAS28 (using tender and swollen joint count, disease activity and sedimentation rate)), blood pressure measured over a 24 hour period, and tissue sodium (using Magnetic Resonance Imaging (MRI)).

If a relatively simple dietary modification has a clinically important effect on inflammation and blood pressure regulation in vivo in patients with RA, this will have far-reaching implications for the treatment of RA and prevention of Cardiovascular disease in this population.

Enrollment

18 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male and female patients older than 18 years who are willing to participate.
  2. Satisfy the ACR criteria for the diagnosis of RA.
  3. Have stable disease activity as evidenced by no clinically meaningful change in immunomodulating or corticosteroid therapy in the past 1 month.
  4. Have moderate disease activity as reflected by a minimum of 3 swollen and tender joints.

Exclusion criteria

  1. Pregnancy
  2. Receiving dialysis
  3. Organ or bone marrow transplant
  4. Taking diuretics, uncontrolled hypertension (>160/100 mmHg), or cardiac failure requiring treatment.
  5. Severe edema (as judged by the investigator)
  6. Diabetes mellitus treated with an insulin pump
  7. Major surgery within the previous 3 months
  8. Severe co-morbid conditions such as active cancer likely to compromise study participation
  9. Unwillingness, or other inability, to cooperate
  10. Contraindication to MRI
  11. Presence of a condition that could make 24-hour blood pressure monitoring difficult: atrial fibrillation, inability to operate machine, receiving anticoagulants, presence of a condition that in the opinion of the investigator may be exacerbated by blood pressure cuff inflation (e.g., lymphedema).

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

18 participants in 2 patient groups

low salt diet
Other group
Description:
low-sodium diet (50mmol/24hours x 8 weeks ) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
Treatment:
Other: salt
high salt diet
Other group
Description:
high-sodium diet (200mmol/24hours x 8weeks) Subjects will choose a rotation of low-sodium meals from a predetermined list from a commercial vendor (Mom's Meals) that will be used to provide 2 meals (lunch and dinner)/day that the vendor will deliver at approximately 7 day intervals. Staff of the Vanderbilt Diet,Body Composition, and Human Metabolism Core determine breakfast and snacks appropriate for theHS andLS diets and provide instructions to subjects.
Treatment:
Other: salt

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Charles M Stein, MBChB; Annette M Oeser, MLAS, CCRP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems